Acquiring Company
Sudarshan Pharma
Acquired Company
MedTherapy Biotechnology
Visakhapatnam
BostonManufacturingBiotechnologyPharmaceuticalBiotechnologyHealth CareDescription
Sudarshan Pharma Industries has approved the acquisition of a 9.50% stake in MedTherapy Biotechnology Inc., a US-based cancer therapy company. The transaction involves purchasing approximately 24,23,675.64 shares and aims to enhance Sudarshan Pharma's presence in the US market. The acquisition is expected to be completed by March 31, 2027, pending necessary approvals.
Don't miss Sudarshan Pharma's next move
Get an email the moment Sudarshan Pharma makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired MedTherapy Biotechnology?
MedTherapy Biotechnology was acquired by Sudarshan Pharma, based in Visakhapatnam. The deal was reported on September 5, 2026. Sudarshan Pharma is a prominent pharmaceutical company focused on developing and manufacturing innovative healthcare solutions. Sudarshan Pharma is privately held and operates in Manufacturing.
When did Sudarshan Pharma acquire MedTherapy Biotechnology?
Sudarshan Pharma's acquisition of MedTherapy Biotechnology was reported on September 5, 2026. Sudarshan Pharma Industries has approved the acquisition of a 9.50% stake in MedTherapy Biotechnology Inc., a US-based cancer therapy company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MedTherapy Biotechnology do?
MedTherapy Biotechnology Inc. is a cancer cell and gene therapy company incorporated in Delaware, USA. Founded in 2018 by experts from Harvard and Novartis, it operates as an integrated CAR-T Cell CDMO. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.